BioCentury
ARTICLE | Clinical News

Vidofludimus: Preliminary Phase IIa data

November 8, 2010 8:00 AM UTC

Preliminary data from the open-label, single-arm, international Phase IIa ENTRANCE trial in 26 evaluable corticosteroid-dependent patients with Crohn's disease or ulcerative colitis (UC) showed that o...